Navigation Links
Solos Endoscopy, Inc. Develops Specialized Endocoupler for the MammoView(TM)

BOSTON, April 2 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (OTC Pink Sheets: SNDY) is pleased to announce that the Company has developed a new endocoupler with an eye piece for the MammoView(TM) system. Along with its current endocoupler, it will allow the MammoView scope to be used by a majority of the video systems currently in the market place. Solos has already started to market the new endocoupler to those customers that previously could not utilize the standard endocoupler. The new MammoView Endocoupler will allow healthcare facilities to have more flexibility because it allow them to utilize any video system at their disposal.

"The new MammoView(TM) endocoupler enables us to offer the MammoView system to a wider customer base that was previously excluded because of the incompatibility of the original endocoupler," stated Bob Segersten, President of Solos Endoscopy, Inc.

Solos Endoscopy recently announced that the Company received a purchase order for its MammoView(TM) line of surgical endoscopy instruments from Sharp Healthcare, one of the leading healthcare providers in the San Diego region.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

SOURCE Solos Endoscopy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Solos Endoscopy, Inc. Receives Purchase Order from Leading San Diego Healthcare Provider
2. Solos Endoscopy, Inc. Successfully Completes FDA Inspection
3. Solos Endoscopy, Inc. Receives Purchase Order from Major Connecticut Hospital for the MammoView(TM)
4. Solos Endoscopy, Inc.s Breast Endoscopy System Featured in January Issue of Outpatient Surgery Magazine
5. Solos Endoscopy, Inc.s MammoView(TM) Featured in December Issue of Surgical Products Magazine
6. Solos Endoscopy, Inc. Posts First Nine Months Financials for 2008 on
7. Solos Endoscopy, Inc. Receives Purchase Order from Cleveland Clinic
8. Solos Endoscopy, Inc. Increases Sales Revenue for October 2008 by Over 10% as Compared to Last Year
9. Solos Endoscopy, Inc.s Mammo View(TM) System Now Used in Womens Hospital of Baton Rouge, LA
10. Solos Endoscopy, Inc. Posts First Six Months Financials of 2008 on
11. Siemens Further Develops its syngo Dynamics Solution
Post Your Comments:
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: